Global health leaders are faced with a proliferation of falsified and substandard medicines that threaten public health. Governments and health policymakers need more data about the benefits of quality medicine to make strategic decisions about where to invest scarce resources. The USP Quality Institute sponsors much-needed research to enable evidence-based policy decisions that can help increase the availability of quality medicines everywhere, building a foundation for a healthier world.
The Fellowship in Quality of Medical Products is the signature program of the USP Quality Institute. Through the fellowship program, USP partners with leading academic institutions around the world to develop and disseminate research addressing evidence gaps around quality medicines, ultimately strengthening the knowledge base on the impact of quality.
